Clinical Usefulness of Serum CA 125 in Patients with Endometriosis

Shimane journal of medical science Volume 9 Issue 2 Page 82-88 published_at 1986-03-01
アクセス数 : 1059
ダウンロード数 : 74

今月のアクセス数 : 72
今月のダウンロード数 : 2
File
m003000902003.pdf 333 KB エンバーゴ : 2015-10-18
Title
Clinical Usefulness of Serum CA 125 in Patients with Endometriosis
Creator
Takahashi Kentaro
Nagata Hiroko
Yamane Yoshio
Yoshino Kazuo
Shibukawa Toshihiko
Murao Fuminori
Kitao Manabu
Source Title
Shimane journal of medical science
Volume 9
Issue 2
Start Page 82
End Page 88
Journal Identifire
ISSN 03865959
EISSN 24332410
Descriptions
Serum CA 125 levels in patients with endometriosis were elevated (35 U/ml or higher) in 88.9% (32/36). CA 125 levels correlated well with the response to Danazol treatment. Using this marker, myoma uteri and adenomyosis can be differentiated pre-operatively and the follow up with Danazol treatment in patients with endometriosis can be monitored.
Subjects
tumor marker ( Other)
CA 125 ( Other)
endometriosis ( Other)
Language
eng
Resource Type departmental bulletin paper
Publisher
Shimane Medical University
Date of Issued 1986-03-01
Publish Type Version of Record
Access Rights open access
Relation
[NCID] AA00841586